Novavax
Utility Patent Applications

Last updated:

List of all Novavax patents 12 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE External link
Filling date: 6 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: METHODS FOR PREVENTING DISEASE OR DISORDER CAUSED BY RSV INFECTION External link
Filling date: 6 Sep 2025 Issue date: 5 May 2022
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 28 Apr 2022
Application
Utility: MULTIVALENT INFLUENZA NANOPARTICLE VACCINES External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2022
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 13 May 2021
Application
Utility: VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY External link
Filling date: 6 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE External link
Filling date: 6 Sep 2025 Issue date: 19 Mar 2020
Application
Utility: MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE External link
Filling date: 6 Sep 2025 Issue date: 30 Jan 2020
Application
Utility: MULTIVALENT INFLUENZA NANOPARTICLE VACCINES External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs) External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019

Showing 1 to 12 of 12 patents.